Riggs Community Health Center Inc - Medicare Primary Care in Lafayette, IN

Riggs Community Health Center Inc is a medicare enrolled primary clinic (Clinic/center - Federally Qualified Health Center (fqhc)) in Lafayette, Indiana. The current practice location for Riggs Community Health Center Inc is 1716 Hartford St, Lafayette, Indiana. For appointments, you can reach them via phone at (765) 742-1567. The mailing address for Riggs Community Health Center Inc is 1716 Hartford St, Lafayette, Indiana and phone number is (765) 742-1567.

Riggs Community Health Center Inc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1386660900. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (765) 742-1567.

Contact Information

Riggs Community Health Center Inc
1716 Hartford St
Lafayette
IN 47904-2138
(765) 742-1567
(765) 742-2750

Primary Care Clinic Profile

Full NameRiggs Community Health Center Inc
SpecialityClinic/Center
Location1716 Hartford St, Lafayette, Indiana
Authorized Official Name and PositionBambi Mcquade-jones (PRESIDENT & CEO)
Authorized Official Contact7657421567
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Riggs Community Health Center Inc
1716 Hartford St
Lafayette
IN 47904-2138

Ph: (765) 742-1567
Riggs Community Health Center Inc
1716 Hartford St
Lafayette
IN 47904-2138

Ph: (765) 742-1567

NPI Details:

NPI Number1386660900
Provider Enumeration Date07/15/2006
Last Update Date07/21/2022

Medicare PECOS Information:

Medicare PECOS PAC ID2365432226
Medicare Enrollment IDO20040513001185

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Riggs Community Health Center Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1386660900NPI-NPPES
100232630MedicaidIN
300062714MedicaidIN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QF0400XClinic/center - Federally Qualified Health Center (fqhc) (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Riggs Community Health Center Inc acts as a billing entity for following providers:
Provider NameNancy E Edwards
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407881006
PECOS PAC ID: 5890720577
Enrollment ID: I20050930000611

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameScott L Sinnott
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1366401184
PECOS PAC ID: 9234158890
Enrollment ID: I20051114000624

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameGregory Mark French
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1922159847
PECOS PAC ID: 2567560022
Enrollment ID: I20070606000510

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameBambi S Mcquade-jones
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548390842
PECOS PAC ID: 8123176948
Enrollment ID: I20090528000431

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameValerie L Legacy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1376856278
PECOS PAC ID: 8921123878
Enrollment ID: I20100915000565

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameApril R Fife
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1215285952
PECOS PAC ID: 8325290273
Enrollment ID: I20121129000123

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameSuma Nagaraj
Provider TypePractitioner - Pediatric Medicine
Provider IdentifiersNPI Number: 1386954048
PECOS PAC ID: 9234365636
Enrollment ID: I20131113000474

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameJeanne M Wilton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1346250586
PECOS PAC ID: 0547366999
Enrollment ID: I20140326001838

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameSusan Foster
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1467833988
PECOS PAC ID: 6507176302
Enrollment ID: I20151106001505

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameMegan Shanley
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1740645860
PECOS PAC ID: 4183927650
Enrollment ID: I20160119000233

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTyra Gordon
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1265627483
PECOS PAC ID: 5890927214
Enrollment ID: I20160802000510

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameRachael E Drye
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1447669213
PECOS PAC ID: 7810284833
Enrollment ID: I20160919002789

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameQiaorong Liu
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851812747
PECOS PAC ID: 2264703941
Enrollment ID: I20170731002081

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameWilberforce Asare
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1285124628
PECOS PAC ID: 9335496728
Enrollment ID: I20180717000228

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameJeffrey Michael Tessman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235611625
PECOS PAC ID: 4183978620
Enrollment ID: I20181119002693

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameRebekah Hurst
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013486588
PECOS PAC ID: 9638416928
Enrollment ID: I20190124001156

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTimothy Poquette
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1427613447
PECOS PAC ID: 9032446844
Enrollment ID: I20190815002812

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameAmy R Kornhauser
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1770137598
PECOS PAC ID: 4385973296
Enrollment ID: I20190830002974

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameRita Becker
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962058743
PECOS PAC ID: 1658600572
Enrollment ID: I20190830002989

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameDavid Beine
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508164484
PECOS PAC ID: 8729317607
Enrollment ID: I20190903002582

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameRenee L Weathington
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679120653
PECOS PAC ID: 8022441351
Enrollment ID: I20191127001033

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameKristen Gaumer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1104476621
PECOS PAC ID: 4880014794
Enrollment ID: I20201014003761

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameChristy L Chen
Provider TypePractitioner - Dentist
Provider IdentifiersNPI Number: 1386173862
PECOS PAC ID: 3870865710
Enrollment ID: I20201015000858

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameCassandra Dawn Selby
Provider TypePractitioner - Certified Nurse Midwife (cnm)
Provider IdentifiersNPI Number: 1639320641
PECOS PAC ID: 5193912202
Enrollment ID: I20201119003182

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTasha Denise Snyder
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1043814932
PECOS PAC ID: 4284048836
Enrollment ID: I20210122001480

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTyler Mark Frizzi
Provider TypePractitioner - Chiropractic
Provider IdentifiersNPI Number: 1053901892
PECOS PAC ID: 6002225588
Enrollment ID: I20210513001143

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameMadeleine J St. James
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922612530
PECOS PAC ID: 7719383918
Enrollment ID: I20210914002593

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTracy D Sapp
Provider TypePractitioner - Dentist
Provider IdentifiersNPI Number: 1902864804
PECOS PAC ID: 6800195595
Enrollment ID: I20220120001433

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameIndia C Tapplar
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366116709
PECOS PAC ID: 8921492273
Enrollment ID: I20220302001222

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTeresa Kathleen Hocking
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871241448
PECOS PAC ID: 6103203484
Enrollment ID: I20220509000723

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameHaileigh Krotz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1568076628
PECOS PAC ID: 4385022284
Enrollment ID: I20220606001505

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameMara N Humberg
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1760089445
PECOS PAC ID: 5698155869
Enrollment ID: I20220706000408

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameChristina Lynn Fleck
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720719990
PECOS PAC ID: 2365825759
Enrollment ID: I20220817003353

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameIrina Paterson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1518634203
PECOS PAC ID: 7315321395
Enrollment ID: I20220825002567

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameJinhai Zhang
Provider TypePractitioner - Dentist
Provider IdentifiersNPI Number: 1083368708
PECOS PAC ID: 7113387168
Enrollment ID: I20230721001876

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameKaitlin Mackenzie Thomas
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881313542
PECOS PAC ID: 9436510773
Enrollment ID: I20230802001955

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameJacinta Brooke Langley
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659091023
PECOS PAC ID: 6507227733
Enrollment ID: I20230803001693

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameRoshini Durga Paruchuri
Provider TypePractitioner - Dentist
Provider IdentifiersNPI Number: 1376063990
PECOS PAC ID: 2860762556
Enrollment ID: I20230915001772

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameCara Marie Wilson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720707375
PECOS PAC ID: 9133583578
Enrollment ID: I20230918003813

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameOlushola Oluwole Ajadi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1588348858
PECOS PAC ID: 8123472354
Enrollment ID: I20230921003073

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameTanya Marie Neal
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1316672884
PECOS PAC ID: 7416301957
Enrollment ID: I20231002002695

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameDenise Shaw
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124720560
PECOS PAC ID: 8527411750
Enrollment ID: I20240124002188

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

Provider NameDustin Lafollette
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1982485926
PECOS PAC ID: 5294178372
Enrollment ID: I20240206000815

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more Medical News

› Verified 1 days ago

News Archive

Hispanic population health issues portend challenges for health care system

The Hispanic population boom recorded in last week's census data portends huge challenges for a health care system that has struggled to meet that community's needs.

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

Research team creates first 'lipidome' of human plasma

Human blood is famously fraught with fats; now researchers have a specific idea of just how numerous and diverse these lipids actually are. A national research team, led by scientists at the University of California, San Diego School of Medicine, has created the first "lipidome" of human plasma, identifying and quantifying almost 600 distinct fat species circulating in human blood.

Stents can be as effective as surgery for many patients with left main coronary artery disease

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, are as effective as surgery for many patients with a blockage in the left main coronary artery.

YM Biosciences to sell maximum of 7,750,000 common shares through Controlled Equity Offering

YM BioSciences Inc., announced today that it has filed a prospectus supplement to its final base shelf prospectus, dated September 16, 2009, with the Ontario Securities Commission, and a supplement to its U.S. prospectus, dated September 16, 2009, forming part of its U.S. registration statement, with the United States Securities and Exchange Commission.

Read more News

› Verified 1 days ago


Clinic/Center in Lafayette, IN

Thomas Li Consulting Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 427 Main St Ste 210, Lafayette, IN 47901
Phone: 765-404-8099    
Kelly Nutrition, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5134 Florence Ln, Lafayette, IN 47905
Phone: 765-413-5609    
St Elizabeth Infusion Services
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1345 Unity Pl, Suite 365, Lafayette, IN 47905
Phone: 765-446-5417    Fax: 765-446-5317
Fundamental Health, Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1221 S Creasy Ln Ste K3, Lafayette, IN 47905
Phone: 765-838-2310    Fax: 765-838-1035
Horizon Oncology Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1345 Unity Pl, Ste 365, Lafayette, IN 47905
Phone: 765-446-5111    Fax: 765-446-5165
Valley Oaks Health Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2323 Ferry St, Lafayette, IN 47904
Phone: 866-682-5539    
Estep Family Medicine
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3774 Bayley Dr, Suite A, Lafayette, IN 47905
Phone: 765-446-5417    Fax: 765-446-5317

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.